Unicycive Therapeutics, Inc. — 8-K Filings
61 8-K filings on record
This page lists all 8-K filings submitted to the SEC by Unicycive Therapeutics, Inc. (UNCY), sorted by most recent first. Each row links to the full filing on EdgarLookup. Unicycive Therapeutics, Inc. has filed 61 8-K documents with the SEC since 2019. To view all SEC filings by Unicycive Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
NT 10-Q
POS AM
PRE 14A
S-1
S-1/A
S-3
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | CURRENT REPORT | 0001213900-22-083051 | Dec 28, 2022 | — |
| 8-K | CURRENT REPORT | 0001213900-22-071746 | Nov 14, 2022 | — |
| 8-K | CURRENT REPORT | 0001213900-22-048233 | Aug 15, 2022 | — |
| 8-K | CURRENT REPORT | 0001213900-22-045405 | Aug 8, 2022 | Aug 2, 2022 |
| 8-K | CURRENT REPORT | 0001213900-22-039989 | Jul 18, 2022 | Jul 14, 2022 |
| 8-K | CURRENT REPORT | 0001213900-22-033329 | Jun 16, 2022 | Jun 15, 2022 |
| 8-K | CURRENT REPORT | 0001213900-22-025753 | May 12, 2022 | — |
| 8-K | CURRENT REPORT | 0001213900-22-016502 | Mar 31, 2022 | — |
| 8-K | CURRENT REPORT | 0001213900-21-062237 | Nov 29, 2021 | — |
| 8-K | CURRENT REPORT | 0001213900-21-058355 | Nov 12, 2021 | Nov 11, 2021 |
| 8-K | CURRENT REPORT | 0001213900-21-042692 | Aug 16, 2021 | — |